WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

High Return Rate: Are Chinese Innovative Drugs Facing a "Breakup" Crisis in Ov... Analysis of Booming License-Out Deals Reveals a Concerning Trend of Terminated Collaborations for Chinese Pharmaceutical Companies, according to a recent feature article ...
(4/29/2025)

High Return Rate: Are Chinese Innovative Drugs... (4/29/2025)

China Aims for Significant Pharma Industry Dig... (4/26/2025)

MNC Pharma's Q1/2025 China Performance: Diverg... (4/25/2025)

Cell Therapy to AI: How J&J Has Been Sourcing ... (4/25/2025)

China Biopharma Tracker – March 2025 (PharmaD... (4/24/2025)

US Capital Crunch Pushes China Biotechs to Rou... (4/24/2025)

Cheaper Chinese HPV Vaccines Turn Merck's Gard... (4/23/2025)

China Broadens Healthcare Access: Foreign Doct... (4/22/2025)

As US Decouples, China Strengthens Biotech Tie... (4/22/2025)

Chinese drugmakers weigh options as US mulls p... (4/18/2025)

Interpretation of the Anti-Monopoly Guidelines... (4/17/2025)

This Pharma Company Is Betting Big On A Chines... (4/17/2025)

AstraZeneca's China Business Recovers in... (4/29/2025) China Orders Drugmakers, Hospitals to St... (4/29/2025) State Council Approves Draft Medical Sec... (4/29/2025) 53 Original Research Drugs Approved in C... (4/29/2025) BeiGene's Novel Cancer Drug Sonrotoclax ... (4/29/2025) ConjugateBio Secures Exclusive Option fo... (4/29/2025) Europe Emerges as Key Partner for China ... (4/29/2025) AmCham China Reports Chinese Tariff Exem... (4/29/2025) Innovent Announces NMPA Approval of Lime... (4/29/2025) InnoCare's Orelabrutinib Receives NMPA A... (4/29/2025) Hengrui Secures Approval for Hong Kong I... (4/29/2025) China NMPA Suspends Digoxin API Imports ... (4/29/2025) China's Hospital Drug Market Shows Sligh... (4/29/2025) Frontera's Gene Therapy FT-017 Achieves ... (4/29/2025) JW and Juno Forge sLVV Licensing Agreeme... (4/29/2025) XellSmart Receives NMPA Approval for Lan... (4/29/2025) CentyMed's Novel EGFR/CD3 BsAb CMDE005 R... (4/29/2025) Ribo Life Science Files for IPO on HKSE,... (4/29/2025)

China's Hospital Drug Market Shows Slight Growth in 202... China Unveils Ambitious Plan to Boost Health-Related Co... Chinese VMS OTC Market Growth Slowed to 2.7% in 2024 Newish Tech Secures Series B Financing to Advance Next-... China's Retail Pharmacy Market Reaches CNY 574 Billion ...

Qyuns Sets Up Newco for Global Rights to Its Novel Long... DualityBio and AstraZeneca Unite to Investigate Novel L... 3SBio Advances Novel MUC17-Targeting Therapy SSS59 into... PegBio Poised for IPO on Hong Kong Stock Exchange Follo... Ribo Life Science Files for IPO on HKSE, Backed by CICC...

China NMPA Suspends Digoxin API Imports from VITAL LABS... CDE Issues the List of Reference Formulations for GQCE ... China Seeks Feedback on ICH Draft Guideline M13B for Bi... China Issues New Guidelines to Streamline Mainland Regi... China Revises Military Drug Administration Measures to ...

NHC Ministers Meet with Top Pharma MNC Executives Beijing Unveils Ambitious Policy Package to Supercharge... China's BMI Fund Surpasses CNY16.5 Trillion with 11% An... Growing Awareness and Expanding Treatment Options for S... China Sets Ambitious Nutritional Targets for 2030 to Im...

State Council Approves Draft Medical Security Law, Stre... Novo Nordisk Sues KBP Biosciences for $830 Million Over... State Council Releases Final Antitrust Guidelines for t... Bayer Initiates Patent Infringement Lawsuit Against Hen... Oxford Nanopore Sues Chinese Biotech Giant BGI Over All...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

Akeso's BsAb Shows Promising Survival Benefit in Lung C... Innovent Initiates Global Phase 1 Trial for ADC IBI3020... CentyMed's Novel EGFR/CD3 BsAb CMDE005 Receives FDA Gre... XellSmart Receives NMPA Approval for Landmark Trial of... Frontera's Gene Therapy FT-017 Achieves Dual Regulatory...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...